6-7370059-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001170692.2(CAGE1):āc.1753A>Gā(p.Lys585Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000312 in 1,602,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001170692.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAGE1 | NM_001170692.2 | c.1753A>G | p.Lys585Glu | missense_variant | 6/14 | ENST00000502583.6 | NP_001164163.1 | |
CAGE1 | NM_001170693.2 | c.1753A>G | p.Lys585Glu | missense_variant | 6/13 | NP_001164164.1 | ||
CAGE1 | NM_205864.3 | c.1345A>G | p.Lys449Glu | missense_variant | 5/11 | NP_995586.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAGE1 | ENST00000502583.6 | c.1753A>G | p.Lys585Glu | missense_variant | 6/14 | 5 | NM_001170692.2 | ENSP00000425493.1 | ||
CAGE1 | ENST00000338150.8 | c.1753A>G | p.Lys585Glu | missense_variant | 6/13 | 2 | ENSP00000338107.4 | |||
CAGE1 | ENST00000379918.8 | c.1753A>G | p.Lys585Glu | missense_variant | 6/14 | 5 | ENSP00000369250.4 | |||
CAGE1 | ENST00000512086.5 | c.1753A>G | p.Lys585Glu | missense_variant | 6/12 | 5 | ENSP00000427583.1 | |||
CAGE1 | ENST00000296742.11 | c.1345A>G | p.Lys449Glu | missense_variant | 5/11 | 1 | ENSP00000296742.7 | |||
CAGE1 | ENST00000442019.6 | n.*1019A>G | non_coding_transcript_exon_variant | 6/14 | 1 | ENSP00000391746.2 | ||||
CAGE1 | ENST00000458291.6 | n.1753A>G | non_coding_transcript_exon_variant | 6/14 | 1 | ENSP00000390644.2 | ||||
CAGE1 | ENST00000442019.6 | n.*1019A>G | 3_prime_UTR_variant | 6/14 | 1 | ENSP00000391746.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000126 AC: 3AN: 237682Hom.: 0 AF XY: 0.00000775 AC XY: 1AN XY: 129056
GnomAD4 exome AF: 0.00000276 AC: 4AN: 1450830Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 721538
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2024 | The c.1753A>G (p.K585E) alteration is located in exon 6 (coding exon 5) of the CAGE1 gene. This alteration results from a A to G substitution at nucleotide position 1753, causing the lysine (K) at amino acid position 585 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at